Details
Category: Volume 11 Issue 04 April 2023
Hits: 362

Title: Prevalence of Symptomatic Positive Cases of COVID-19 among different aged group from different locations of Indore: Hospital Based Study

Authors: Rajesh Kumar Meena, Dr Madhurendra Rajput, Dr Farha Siddiqui

 DOI: https://dx.doi.org/10.18535/jmscr/v11i4.10

Abstract

Introduction: Coronavirus affected all aged grouped patients. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) is the main pathogen which caused Coronovirus Disease 19 (COVID-19), initially detected in Wuhan City, China in Late 2019.Both young aged as well as elder aged persons were affected from Coronavirus. So, in our present study, we study about the prevalence of COVID-19 among different aged group of different location of Indore state.

Aims & Objectives

  • To study the prevalence of positive COVID-19 cases (symptomatic) in different aged group patients.
  • To study the prevalence of various variants of positive COVID-19 cases (symptomatic) among Rural and Urban area.

Materials and Methods: A total of 488 positive cases (Symptomatic) were included in our study aged between 0 to 90 years. Study was conducted in Department of Microbiology, Index Medical College and Research Center, Indore (M.P.) between 2020 to 2022.The Genome sequence of all the positive samples were identified through RT-PCR Test to detect the variant of COVID-19 and also to detected the symptomatic positive cases.

Results and Discussions: The prevalence of positive sample according to different aged group was showed and it found that highest number of positive cases was found between 11 to 20 years followed by 21 to 30 year aged group patients and the number was 183 and 166 respectively. That the prevalence of positive cases both in urban and rural area and the percentage of positive cases in urban and rural is 52.46% and 47.54% respectively. Out of 488 positive cases, 256 cases from urban area and remaining 232 cases from rural area.

Conclusion: Prevalence of Corona virus was much higher in younger group than that of elder one. The prevalence for both urban and rural region was common for Alpha variant followed by Delta variant. The prevalence of Urban region was slightly high than that of rural region. Regular health check should be done by the government both in private and government sectors and proper treatment should be given to the patients who were infected.

Keywords: Age, Urban, Rural, COVID-19.

References

  1. Origin of SARS-CoV-2 [Internet]. 2020 [cited 2021 November]. Available from: https://apps.who.int/iris/bitstream/handle/10665/332197/WHO-2019-nCoV-FAQVirus_origin-2020.1-eng.pdf
  2. Johns Hopkins University, Coronavirus Resource Center. 2020 [cited 2021 November 28]. Available from: https://coronavirus.jhu.edu/map.html
  3. Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases: interim guidance, 2 November 2021. World Health Organization; 2020. Available from: https://apps.who.int/iris/handle/10665/331329
  4. Bar-On YM, Flamholz A, Phillips R, Milo R. SARS-CoV-2 (COVID-19) by the numbers. Elife. 2020 January 2;9:e57309. Available from: https://pubmed.ncbi.nlm.nih.gov/32228860.
  5. Meyerowitz-Katz G, Merone L. A systematic review and meta-analysis of published research data on COVID-19 infection-fatality rates. medRxiv . 2020 Jul 7;2020.05.03.20089854.
  6. Levin AT, Hanage WP, Owusu-Boaitey N, Cochran KB, Walsh SP, Meyerowitz-Katz G. Assessing the Age Specificity of Infection Fatality Rates for COVID-19: Systematic Review, Meta-Analysis, and Public Policy Implications. medRxiv. 2020 Oct 8;2020.07.23.20160895
  7. Ioannidis J. The infection fatality rate of COVID-19 inferred from seroprevalence data. medRxiv. 2020 Jan 1;2020.05.13.20101253
  8. Coronavirus disease 2019 (COVID-19) in the EU/EEA and the UK– ninth update. 2020;2019(April).
  9. Onder G, Rezza G, Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. Vol. 323, JAMA - Journal of the American Medical Association. American Medical Association; 2020 p. 1775–6.
  10. Kalantari H, Tabrizi AHH, Foroohi F. Determination of COVID-19 prevalence with regards to age range of patients referring to the hospitals located in western Tehran, Iran. Gene Rep. 2020 Dec;21:100910. 
  1. Li H, Wang S, Zhong F, Bao W, Li Y, Liu L, Wang H, He Y. Age-Dependent Risks of Incidence and Mortality of COVID-19 in Hubei Province and Other Parts of China. Front Med (Lausanne). 2020 Apr 30;7:190.
  2. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Apr 7;323(13):1239-1242.
  3. Murhekar MV et al ICMR Serosurveillance Group. SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020-January 2021. Int J Infect Dis. 2021 Jul;108:145-155.
  4. Malancha Chakrabarty and Sobha Suri. Winning the COVID-19 Battle in Rural India: A Blueprint for Action. Cited on June 2021. www. https://www.orfonline.org/research/winning-the-covid-19-battle-in-rural-india-a-blueprint-for-action/

Corresponding Author

Rajesh Kumar Meena

Ph.D. Scholar, Department of Microbiogy, Index Medical College, Hospital and Research Center, Indore (M.P.)